CHD Chemicals Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

Quality Assessment: Weak Long-Term Fundamentals Persist

CHD Chemicals’ quality metrics remain under pressure, reflecting its ongoing operational challenges. The company reported flat financial performance in Q1 FY26-27, with an operating loss and a negative EBITDA of ₹-0.26 crore. This negative earnings before interest, taxes, depreciation and amortisation underscores the company’s inability to generate positive cash flow from core operations.

Further, the firm’s long-term fundamental strength is rated as weak, with a concerning Debt to EBITDA ratio of -5.78 times, indicating a high debt burden relative to earnings. This ratio suggests limited capacity to service debt, raising solvency risks. Additionally, the average Return on Equity (ROE) stands at a mere 0.95%, signalling low profitability generated per unit of shareholders’ funds. These factors collectively weigh heavily on the company’s quality grade, justifying a cautious stance despite technical improvements.

Valuation: Risky and Elevated Compared to Historical Levels

From a valuation perspective, CHD Chemicals is trading at levels that appear risky relative to its historical averages. The stock’s recent price of ₹6.30 is close to its 52-week high of ₹7.24, while the 52-week low was ₹4.11. Despite this price appreciation, the company’s earnings have declined by 32% over the past year, which raises concerns about the sustainability of current valuations.

Moreover, the stock’s micro-cap status and low liquidity add to valuation risk, as smaller companies often experience higher volatility and wider bid-ask spreads. Investors should be wary of the premium being paid in the context of deteriorating profitability and negative operating cash flows.

Financial Trend: Flat Performance Amidst Declining Profitability

The company’s recent quarterly results reflect a flat financial trend, with no significant improvement in revenues or profitability. The operating losses and negative EBITDA highlight ongoing operational inefficiencies. Over the past year, while the stock price has appreciated by 11.5%, the company’s profits have contracted by 32%, indicating a disconnect between market performance and underlying earnings.

CHD Chemicals’ ability to generate returns remains limited, as evidenced by its low ROE and high leverage. The weak financial trend suggests that the company has yet to stabilise its core operations or improve its earnings trajectory, which is a critical consideration for long-term investors.

Technical Analysis: Shift to Mildly Bullish Momentum Spurs Upgrade

The primary catalyst for the upgrade from Strong Sell to Sell is the improvement in technical indicators. The technical trend has shifted from sideways to mildly bullish, supported by several key signals:

• MACD: Weekly readings are bullish, while monthly readings are mildly bullish, indicating positive momentum in both short and medium terms.
• Bollinger Bands: Weekly indicators show mild bullishness, with monthly bands confirming a bullish trend, suggesting increasing price volatility in favour of upward movement.
• KST (Know Sure Thing): Both weekly and monthly KST indicators are mildly bullish, reinforcing the positive momentum.
• Dow Theory: Weekly signals are mildly bullish, although monthly signals remain mildly bearish, reflecting some caution in the longer term.

However, some technical indicators remain mixed or bearish. The daily moving averages are mildly bearish, and the Relative Strength Index (RSI) on both weekly and monthly charts shows no clear signal. This mixed technical picture suggests cautious optimism rather than a strong bullish conviction.

On the trading front, the stock has outperformed the Sensex and BSE500 indices over multiple periods. For example, it delivered a 25.75% return over the past month compared to the Sensex’s -6.13%, and a 16.02% year-to-date return versus the Sensex’s -14.89%. This market-beating performance despite weak fundamentals is likely a factor in the technical upgrade.

Market Context and Shareholding

CHD Chemicals operates within the miscellaneous industry and sector, with a micro-cap market capitalisation. The majority of its shares are held by non-institutional investors, which can contribute to higher volatility and less predictable trading patterns. The stock’s day change of 13.51% on the latest trading session reflects heightened investor interest, possibly driven by the technical upgrade and short-term momentum.

Conclusion: Upgrade Reflects Technical Optimism Amidst Fundamental Challenges

The upgrade of CHD Chemicals Ltd’s investment rating from Strong Sell to Sell is primarily driven by a shift in technical indicators towards a mildly bullish trend. This technical improvement has encouraged a more positive short-term outlook for the stock, reflected in recent price gains and market-beating returns relative to benchmarks.

However, the company’s fundamental profile remains weak, characterised by flat financial performance, negative EBITDA, high leverage, and low profitability. Valuation risks persist given the stock’s elevated price relative to earnings and micro-cap status. Investors should weigh the technical momentum against these fundamental headwinds before considering exposure.

Overall, CHD Chemicals presents a cautious investment case where technical signals offer some optimism, but fundamental weaknesses and valuation concerns temper enthusiasm. The Sell rating reflects this balanced view, signalling that while the stock may have short-term upside, significant risks remain for long-term investors.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today